Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

ClinicalTrials.gov ID: NCT03033511

Public ClinicalTrials.gov record NCT03033511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, randomized, double-blind, placebo-controlled, multinational, and multicenter study to evaluate the efficacy of rovalpituzumab tesirine as maintenance therapy following first-line platinum-based chemotherapy.

Study identification

NCT ID
NCT03033511
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
748 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 7, 2017 (Actual)
Primary completion
Nov 20, 2019 (Actual)
Completion
Nov 20, 2019 (Actual)
Last update posted
Jul 29, 2021

2017 – 2019

United States locations

U.S. sites
54
U.S. states
28
U.S. cities
51
Facility City State ZIP Site status
Clearview Cancer Institute /ID# 156699 Huntsville Alabama 35805 —
University of South Alabama /ID# 160975 Mobile Alabama 36604-3302 —
Highlands Oncology Group /ID# 156722 Fayetteville Arkansas 72703-4005 —
Marin Cancer Care /ID# 159207 Greenbrae California 94904 —
Ucsd /Id# 157764 La Jolla California 92093 —
LA Hem-Oncology Med Group /ID# 156717 Los Angeles California 90017 —
Palo Alto Veterans Institute for Research /ID# 203695 Palo Alto California 94304-1207 —
St Jude Hospital dba St Joseph /ID# 156526 Santa Rosa California 95403 —
Icri /Id# 157765 Whittier California 90603 —
Kaiser Permanente Lone Tree /ID# 159331 Lone Tree Colorado 80124 —
Christiana Care Health Service /ID# 159212 Newark Delaware 19713 —
Holy Cross Hospital /ID# 156716 Fort Lauderdale Florida 33308 —
University of Florida - Archer /ID# 155799 Gainesville Florida 32610 —
Memorial Cancer Institute /ID# 156673 Hollywood Florida 33021-5421 —
Memorial Cancer Institute /ID# 164052 Hollywood Florida 33021-5421 —
Cancer Specialists of North Florida - Southpoint /ID# 156595 Jacksonville Florida 32256 —
Georgia Cancer Center /ID# 201894 Atlanta Georgia 30342 —
Southeastern Regional Medical /ID# 163064 Newnan Georgia 30265 —
St. Luke's Mountain States Tumor Institute - Boise /ID# 156691 Boise Idaho 83712 —
NorthShore University HealthSystem - Evanston Hospital /ID# 156664 Evanston Illinois 60201 —
Ingalls Memorial Hosp /ID# 156685 Harvey Illinois 60426 —
Goshen Center for Cancer Care /ID# 156682 Goshen Indiana 46526 —
Ashland-Bellefonte Cancer Ctr /ID# 202901 Ashland Kentucky 41101 —
University of Louisville /ID# 156683 Louisville Kentucky 40202 —
Ochsner Clinic Foundation /ID# 159136 Baton Rouge Louisiana 70836-6455 —
Henry Ford Health System /ID# 156712 Detroit Michigan 48202 —
Sparrow Regional Cancer Center, Sparrow Health System /ID# 156590 Lansing Michigan 48912 —
Mayo Clinic - Rochester /ID# 160181 Rochester Minnesota 55905-0001 —
MidAmerica Division, Inc. /ID# 163530 Kansas City Missouri 64132 —
Billings Clinic /ID# 201788 Billings Montana 59101-0733 —
Nebraska Hematology Oncology /ID# 156534 Lincoln Nebraska 68506 —
MD Anderson Cancer Center at Cooper - Camden /ID# 156681 Camden New Jersey 08103 —
Northwell Health - Monter Cancer Center /ID# 159252 Lake Success New York 11042 —
Icahn School of Med Mt. Sinai /ID# 159210 New York New York 10029 —
Stony Brook University Hospital /ID# 159272 Stony Brook New York 11794-8183 —
Montefiore Medical Center /ID# 201845 The Bronx New York 10461 —
Duke University Medical Center /ID# 156706 Durham North Carolina 27710-3000 —
Cone Health /ID# 156689 Greensboro North Carolina 27403 —
Cone Health /ID# 163612 Greensboro North Carolina 27403 —
Eastern Carolina University /ID# 159264 Greenville North Carolina 27834 —
Gabrail Cancer Center Research /ID# 156667 Canton Ohio 44718 —
Kaiser Permanente, NW /ID# 201793 Portland Oregon 97227 —
Thomas Jefferson University /ID# 156719 Philadelphia Pennsylvania 19107-4414 —
VA Pittsburgh HealthcareSystem /ID# 159284 Pittsburgh Pennsylvania 15240 —
Rhode Island Hospital /ID# 160834 Providence Rhode Island 02903 —
Sarah Cannon Research Institute-Chattanooga /ID# 202933 Chattanooga Tennessee 37404-1108 —
Thompson Cancer Survival Ctr /ID# 202460 Knoxville Tennessee 37916 —
Tennessee Oncology-Nashville Centennial /ID# 161168 Nashville Tennessee 37203-1632 —
Univ Medical Ctr Brackenridge /ID# 155798 Austin Texas 78701 —
Parkland Health and Hosp Syste /ID# 170933 Dallas Texas 75235 —
UT Southwestern Medical Center /ID# 157848 Dallas Texas 75390-7208 —
Houston Methodist Hospital - Scurlock Tower /ID# 202323 Houston Texas 77030 —
Medical Oncology Associates /ID# 156715 Spokane Washington 99208 —
West Virginia Univ School Med /ID# 156687 Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 254 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03033511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03033511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →